Found: 7
Select item for more details and to access through your institution.
Targeting phosphoglycerate dehydrogenase in multiple myeloma.
- Published in:
- Experimental Hematology & Oncology, 2021, v. 10, n. 1, p. 1, doi. 10.1186/s40164-020-00196-w
- By:
- Publication type:
- Article
Health-related quality of life in Norwegian adolescents living with chronic fatigue syndrome.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Immunosuppressive adenosine - a novel treatment target for multiple myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e137, doi. 10.1016/j.clml.2019.09.228
- By:
- Publication type:
- Article
Anti-c- MET Nanobody<sup>®</sup> - a new potential drug in multiple myeloma treatment.
- Published in:
- European Journal of Haematology, 2013, v. 91, n. 5, p. 399, doi. 10.1111/ejh.12185
- By:
- Publication type:
- Article
High expression of BCL3 in human myeloma cells is associated with increased proliferation and inferior prognosis.
- Published in:
- European Journal of Haematology, 2009, v. 82, n. 5, p. 354, doi. 10.1111/j.1600-0609.2009.01225.x
- By:
- Publication type:
- Article
Phosphatase of regenerating liver 3 (PRL-3) is overexpressed in human prostate cancer tissue and promotes growth and migration.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Phosphatase of regenerating liver-3 (PRL-3) is overexpressed in classical Hodgkin lymphoma and promotes survival and migration.
- Published in:
- Experimental Hematology & Oncology, 2018, v. 7, n. 1, p. N.PAG, doi. 10.1186/s40164-018-0100-2
- By:
- Publication type:
- Article